Aug 12, 2026 08:32AM
Aug 12, 2026 08:30AM
Aug 6, 2026 08:31AM
Aug 6, 2026 08:31AM
Aug 6, 2026 08:30AM
Aug 6, 2026 08:30AM
Jul 7, 2026 08:33AM Propanc Biopharma signs MOU with Avance Clinical for Phase 1 trial
Jul 7, 2026 08:30AM
Jun 11, 2026 08:30AM
Jun 11, 2026 08:30AM
Mar 3, 2026 08:46AM
Mar 3, 2026 08:45AM
Mar 3, 2026 08:45AM
Feb 5, 2026 08:45AM Propanc Biopharma plans phase 1b trial for cancer therapy PRP in 2026
Feb 5, 2026 08:45AM
Jan 15, 2026 08:45AM
Jan 15, 2026 08:45AM
Aug 21, 2024 09:00AM
Aug 14, 2024 09:00AM
Jul 17, 2024 09:00AM
Jun 25, 2024 09:00AM Propanc Biopharma Receives Certificate of Grant for “Proenzymes Composition” Patent from Japanese Patent Office
Apr 16, 2024 09:00AM
Feb 22, 2024 08:00AM
Dec 13, 2023 09:00AM
Nov 7, 2023 09:00AM
Aug 15, 2023 08:30AM
Jul 13, 2023 08:30AM
Jul 5, 2023 09:00AM Propanc Biopharma Produces Synthetic Recombinant Proenzymes for Cancer Therapy Targeting Advanced Solid Tumors
Jun 22, 2023 09:00AM
Mar 28, 2023 09:03AM
Mar 28, 2023 09:00AM
Mar 16, 2023 09:00AM
Dec 15, 2022 09:00AM
Nov 30, 2022 09:00AM
Nov 15, 2022 09:00AM Propanc Biopharma’s CSO Predicts PRP Could Enhance Therapeutic Effects of Immune Checkpoint Therapy for Pancreatic Cancer
Oct 26, 2022 09:00AM
Sep 29, 2022 09:00AM
Sep 13, 2022 09:00AM
Sep 8, 2022 09:15AM
Aug 16, 2022 09:00AM
Aug 3, 2022 09:00AM
Jul 28, 2022 09:00AM Propanc Biopharma’s CSO Reflects on Unique Anti-Cancer Effects of PRP Discovered Over Past Decade
Jul 12, 2022 09:00AM
Jul 5, 2022 09:00AM
Jun 24, 2022 09:00AM
Jun 24, 2022 09:00AM
Jun 22, 2022 09:00AM
Jun 14, 2022 09:00AM
Jun 1, 2022 09:00AM Propanc Biopharma Believes PRP Reduced Toxicity Will Impact Cancer Patient Lives Significantly
May 26, 2022 09:00AM

328,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All